Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE studyGuy Young, Tadashi Matsushita, Flora Peyvandi et al.|Blood|2025Cited by 38
Efanesoctocog Alfa Population Pharmacokinetics and Repeated Time‐To‐Event Analysis of Bleeds in Adults, Adolescents, and Children with Severe Hemophilia ANancy Wong, Sreeraj Macha, Pratik Bhagunde et al.|The Journal of Clinical Pharmacology|2025Cited by 2